Clearmind Medicine partners with Polyrizon for intranasal MEAI formulation
Go back to Clearmind Medicine partners with Polyrizon for intranasal MEAI formulation| (NASDAQ: CMND) | Delayed: 5.97 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.97 | 52 Week High | $ | |||
| Open | $5.97 | 52 Week Low | $ | |||
| Day High | $5.97 | P/E | N/A | |||
| Day Low | $5.97 | EPS | $ | |||
| Volume | 449 | |||||
| (NASDAQ: PLRZ) | Delayed: 8.58 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.58 | 52 Week High | $ | |||
| Open | $8.58 | 52 Week Low | $ | |||
| Day High | $8.58 | P/E | N/A | |||
| Day Low | $8.58 | EPS | $ | |||
| Volume | 12 | |||||



